https://genentech-clinicaltrials.com2026-02-03https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-evaluating-safety--pharmacokinetics--and-therapeutic-act.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/bc/efficacy-and-safety-of-trastuzumab-emtansine-in-chinese-particip.html2024-06-22https://genentech-clinicaltrials.com/en/trials/cancer/bc/safety--tolerability--and-pharmacokinetic--pk--study-of-dhes0815.html2024-08-13https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-gdc-9545-alone-or-in-combination-with-palbociclib-and.html2025-02-28https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-multiple-immunothe.html2025-02-12https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-ro7198457--personalized-cancer-vaccine--pcv---as-a-si.html2025-03-29https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-ipatasertib-in-combination-with-paclitaxel-as-a-treat.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/bc/to-evaluate-the-safety--tolerability--and-pharmacokinetics-of-gd.html2025-03-19https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-comparing-atezolizumab--anti-pd-l1-antibody--in-68166.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-multiple-immunotherapy-based-treatment-combinations-i.html2024-10-22https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-evaluate-the-pharmacokinetics--efficacy--and-safety-o.html2024-06-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-atezolizumab-and-paclitaxel-versus-placebo-and-paclit.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-the-efficacy-and-safety-of-atezolizumab-plus-chemothe.html2024-11-09https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-investigate-atezolizumab-and-chemotherapy-compared-wi.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-phase-ii-study-comparing-the-efficacy-of-venetoclax---fulvestr.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-evaluate-patient-preference-and-satisfaction-26388.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-evaluate-the-efficacy-and-safety-of-atezoliz-39916.html2024-11-06https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-evaluate-the-efficacy-and-safety-of-pertuzum-08881.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/bc/study-in-participants-with-early-stage-or-locally-advan-28195.html2024-06-22https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-gdc-0810-versus-fulvestrant-in-postmenopausa-72129.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-evaluate-the-efficacy-and-safety-of-trastuzu-87572.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/bc/pertuzumab-with-high-dose-trastuzumab-in-human-epiderma-84588.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-evaluate-the-safety-and-efficacy-of-ipataser-98538.html2024-10-31https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-trastuzumab-emtansine-versus-trastuzumab-as-adjuvant-.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-gdc-9545-in-postmenopausal-women-with-stage--78587.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-ipatasertib-plus-palbociclib-and-fulvestrant-28505.html2024-11-09https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-ipatasertib-in-combination-with-atezolizumab-93464.html2024-09-24https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-gdc-0077--75564.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-trastuzumab-emtansine--kadcyla--plus-pertuzu-91245.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-pertuzumab-in-combination-with-trastuzumab---50542.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-two-arm-study-to-evaluate-the-pharmacokinetics--effic-88813.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-atezolizumab--tecentriq--plus-nab-paclitaxel-22823.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-evaluating-the-efficacy--safety--and-pharmacoki-19834.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-gdc-9545--28702.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-gdc-0927-in-postmenopausal-women-with-locall-71074.html2024-06-21https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-gdc-9545--37336.html2024-09-21https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-the-safety--efficacy--and-pharmacokinetics-o-75095.html2023-03-16https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-trastuzumab-emtansine-in-combination-with-at-19708.html2025-02-19https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-multiple--68522.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-assessing-the-safety-and-efficacy-of-adding-ipa-52566.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-adjuvant--70278.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-adjuvant--58545.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-trastuzumab-emtansine-in-participants-with-h-49753.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-giredestr-26550.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-evaluate-patient-preference-for-home-adminis-86302.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-inavolisi-04316.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-ro7247669---nab-paclitaxel-compared-with-pem-15706.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/the-purpose-of-this-study-is-to-evaluate-the-efficacy-a-74702.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-evaluate-efficacy-and-safety-of-giredestrant-50902.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-investigate-mechanisms-of-resistance-to-brea-16246.html2025-08-11https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-of-pertuzumab-in-addition-to-chemotherapy-and-t-28091.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-evaluating-the-efficacy-and-safety-of-inavolisi-81795.html2025-11-12https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-test-inavolisib-treatments-in-participants-w-22971.html2026-03-10https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-evaluate-the-effect-of-gdc-4198-alone-and-in-51087.html2025-09-05https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-study-to-evaluate-the-safety--pharmacokinetics--and-a-70920.html2025-10-10https://genentech-clinicaltrials.com/en/trials/cancer/bc/to-study-the-effect-of-inavolisib-in-combination-with-f-35021.html2026-02-24https://genentech-clinicaltrials.com/en/trials/cancer/bc/a-phase-ii-study-evaluating-the-efficacy-and-safety-of--91004.html2026-02-17https://genentech-clinicaltrials.com/en/trials/cancer/bc/ro7771950-versus-tucatinib-in-combination-with-trastuzu-54968.html2026-02-27https://genentech-clinicaltrials.com/en/trials/cancer/leukemia/a-study-of-dcll9718s-in-participants-with-relapsed-or-refractory.html2024-06-22https://genentech-clinicaltrials.com/en/trials/cancer/leukemia/a-study-of-idasanutlin-with-cytarabine-versus-cytarabine-plus-pl.html2024-06-22https://genentech-clinicaltrials.com/en/trials/cancer/leukemia/a-safety-and-pharmacokinetic-study-of-btct4465a--mosunetuzumab--.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/leukemia/a-study-to-compare-the-efficacy-and-safety-of-obinutuzu-46860.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/leukemia/a-study-of-obinutuzumab---bendamustine--bg--in-particip-34230.html2024-06-22https://genentech-clinicaltrials.com/en/trials/cancer/leukemia/a-study-to-compare-the-efficacy-and-safety-of-a-combine-77420.html2025-01-14https://genentech-clinicaltrials.com/en/trials/cancer/leukemia/study-to-evaluate-the-safety-and-pharmacokinetics-of-ut-83821.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/leukemia/a-dose-escalation-and-expansion-study-evaluating-the-sa-65126.html2024-06-22https://genentech-clinicaltrials.com/en/trials/cancer/leukemia/a-study-evaluating-the-safety--efficacy--and-pharmacoki-80734.html2025-02-01https://genentech-clinicaltrials.com/en/trials/cancer/leukemia/a-study-to-evaluate-the-benefit-of-venetoclax-plus-ritu-04186.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/leukemia/a-study-to-evaluate-the-effect-of-venetoclax-on-partici-80511.html2025-04-08https://genentech-clinicaltrials.com/en/trials/cancer/oc/a-study-of-atezolizumab-versus-placebo-in-combination-with-pacli.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/oc/an-observational-study-of-avastin--bevacizumab--in-pati-15217.html2025-03-29https://genentech-clinicaltrials.com/en/trials/cancer/oc/a-study-of-the-efficacy-and-safety-of-bevacizumab-in-ch-64415.html2024-10-04https://genentech-clinicaltrials.com/en/trials/cancer/oc/a-clinical-study-of-cobimetinib-administered-in-combina-24843.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/oc/a-study-evaluating-the-safety--pharmacokinetics-and-eff-46472.html2024-06-21https://genentech-clinicaltrials.com/en/trials/cancer/oc/a-study-evaluating-the-efficacy-and-safety-of-biomarker-28995.html2025-03-19https://genentech-clinicaltrials.com/en/trials/cancer/crc/study-of-cobimetinib-in-combination-with-atezolizumab-and-bevaci.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/crc/a-study-evaluating-the-efficacy-and-safety-of-multiple-immunothe.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/crc/a-phase-ib-study-to-evaluate-the-safety--efficacy--and--82576.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/crc/a-study-of-blyg8824a-in-participants-with-locally-advan-69775.html2025-02-12https://genentech-clinicaltrials.com/en/trials/cancer/crc/study-to-evaluate-safety--pharmacokinetics--pharmacodyn-45448.html2025-01-07https://genentech-clinicaltrials.com/en/trials/cancer/crc/a-study-evaluating-the-safety-and-efficacy-of-targeted--57345.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/crc/a-study-to-evaluate-the-efficacy-and-safety-of-inavolis-24002.html2026-01-08https://genentech-clinicaltrials.com/en/trials/cancer/crc/a-study-to-investigate-cea-prit-2-0-in-participants-wit-83037.html2026-02-19https://genentech-clinicaltrials.com/en/trials/cancer/cca/a-study-of-tiragolumab-plus-atezolizumab-and-atezolizum-32500.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/pv/a-study-to-evaluate-the-efficacy--safety--pharmacokinetics-and-p.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/a-study-in-participants-previously-enrolled-in-a-genentech-and-o.html2025-08-11https://genentech-clinicaltrials.com/en/trials/cancer/bladder-cancer/safety-and-pharmacology-study-of-atezolizumab-alone-and-in-combi.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/bladder-cancer/a-study-of-atezolizumab-versus-observation-as-adjuvant-therapy-i.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/bladder-cancer/study-of-atezolizumab-as-monotherapy-and-in-combination-with-pla.html2025-02-25https://genentech-clinicaltrials.com/en/trials/cancer/bladder-cancer/a-study-evaluating-the-efficacy-and-safety-of-multiple--45851.html2025-01-04https://genentech-clinicaltrials.com/en/trials/cancer/bladder-cancer/a-study-of-atezolizumab-versus-placebo-as-adjuvant-ther-94959.html2025-12-30https://genentech-clinicaltrials.com/en/trials/cancer/bladder-cancer/a-study-of-ro7247669-alone-or-in-combination-with-tirag-35445.html2025-02-07https://genentech-clinicaltrials.com/en/trials/cancer/bladder-cancer/a-study-to-evaluate-the-efficacy-and-safety-of-autogene-25008.html2025-12-16https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-atezolizumab-as-neoadjuvant-and-adjuvant-therapy-in-r.html2024-09-20https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-atezolizumab-compared-with-chemotherapy-in-treatment-.html2024-10-24https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-mtig7192a-in-combination-with-atezolizumab-in-chemoth.html2025-01-23https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-to-evaluate-efficacy-and-safety-of-multiple-targeted-the.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/study-to-assess-safety-and-efficacy-of-atezolizumab--mpdl3280a--.html2025-04-01https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-multiple-immunotherapy-based-treatment-combinations-i0.html2025-02-21https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-comparing-adjuvant-alectinib-versus-adjuvant-platinum-ba.html2025-02-06https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/alectinib-compared-with-chemotherapy-in-previously-treated-patie.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-neoadjuvant-atezolizumab-plus-chemotherapy-versus-pla.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-carboplatin-plus-etoposide-with-or-without-atezolizum.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-to-investigate-the-pharmacokinetics--efficacy---50110.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-to-evaluate-and-compare-the-efficacy-and-safety-17318.html2025-03-26https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/prospective-clinicogenomic-program-87790.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-bevacizumab--carboplatin--and-paclitaxel-or--06126.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-atezolizumab-plus-carboplatin-and-etoposide--78663.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-the-efficacy-and-safety-of-ro7198457-in-comb-43212.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-tiragolumab-in-combination-with-atezolizumab-44503.html2025-01-15https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-alectinib--entrectinib--or-vemurafenib-plus--00684.html2025-03-25https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-atezolizumab-in-combination-with-carboplatin-17822.html2024-07-17https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/atezolizumab-consolidation-in-limited-stage-small-cell--22210.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-comparing-alectinib-with-crizotinib-in-treatmen-47622.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/study-of-atezolizumab-in-combination-with-cabozantinib--77103.html2025-02-28https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-atezolizumab-and-tiragolumab-compared-with-d-48756.html2026-02-17https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-atezolizumab-in-combination-with-carboplatin-26891.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-to-compare-the-efficacy-and-safety-of-entrectin-60665.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-evaluating-the-efficacy-and-safety-of-adjuvant--01537.html2025-12-31https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-tiragolumab-in-combination-with-atezolizumab-98469.html2025-12-18https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/study-of-low-dose-radiotherapy--ldrt--concurrent-cispla-79488.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/study-of-atezolizumab-plus-carboplatin-and-etoposide-wi-07254.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-atezolizumab-in-participants-with-programmed-13746.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-atezolizumab-compared-with-docetaxel-in-part-43570.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-atezolizumab-in-combination-with-carboplatin-09998.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-atezolizumab-in-combination-with-carboplatin-84489.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-evaluating-the-safety-and-efficacy-of-neoadjuva-34775.html2025-03-19https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-atezolizumab-compared-with-platinum-doublet--99946.html2025-01-11https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-phase-iii--open-label-study-of-maintenance-lurbinecte-08813.html2025-04-09https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-to-measure-how-much-of-the-study-drug-gdc-6036-is-absorb.html2022-04-22https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-evaluating-the-efficacy-and-safety-of-multiple--44971.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-to-evaluate-participant-and-healthcare-professi-70557.html2024-11-22https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-to-evaluate-safety--tolerability--pharmacokinet-04290.html2025-03-11https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-ro7247669-plus-platinum-based-chemotherapy-v-60649.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/study-of-ro7515629-in-participants-with-hla-g-positive--91237.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-evaluating-the-safety--activity--and-pharmacoki-06656.html2026-01-12https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/study-to-evaluate-the-safety--pharmacokinetics--and-act-84477.html2025-02-28https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-of-tiragolumab-plus-atezolizumab-compared-with--98034.html2025-01-31https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-phase-1b-study-of-atezolizumab-in-combination-with-er-86113.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-evaluating-the-efficacy-and-safety-of-divarasib-87627.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-to-see-how-well-and-how-safely-different-treatm-24461.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/lung-cancer/a-study-evaluating-the-efficacy-and-safety-of-divarasib-53110.html2025-07-04https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/a-study-of-atezolizumab--anti-programmed-death-ligand-1--pd-l1--.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/a-study-of-cobimetinib-administered-as-single-agent-and-in-combi.html2024-06-22https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/dose-escalation-study-of-bfcr4350a-in-participants-with-relapsed.html2025-02-25https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/a-study-evaluating-the-safety-and-pharmacokinetics-of-e-39731.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/a-study-evaluating-the-safety-and-pharmacokinetics-of-e-50454.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/a-study-evaluating-the-safety--pharmacokinetics--and-ac-86713.html2025-01-15https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/a-study-to-evaluate-the-safety-and-pharmacokinetics-of--00382.html2025-02-19https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/a-study-evaluating-the-efficacy-and-safety-of-cevostama-15661.html2025-02-19https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/a-study-evaluating-the-safety-and-efficacy-of-multiple--63288.html2025-02-25https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/a-dose-escalation-study-to-evaluate-the-safety--pharmac-73263.html2025-01-31https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/a-study-evaluating-the-safety--pharmacokinetics--and-ac-10239.html2025-02-01https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/a-study-evaluating-safety--tolerability--and-clinical-a-92792.html2025-02-27https://genentech-clinicaltrials.com/en/trials/cancer/multiple-myeloma/a-study-evaluating-the-pharmacokinetics--safety--and-ef-11754.html2025-04-19https://genentech-clinicaltrials.com/en/trials/cancer/rcc/a-study-of-atezolizumab-as-adjuvant-therapy-in-participants-with.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/rcc/a-study-of-atezolizumab-in-combination-with-bevacizumab-21433.html2024-06-22https://genentech-clinicaltrials.com/en/trials/cancer/rcc/a-study-of-atezolizumab-in-combination-with-cabozantini-46186.html2025-01-15https://genentech-clinicaltrials.com/en/trials/cancer/rcc/a-study-of-atezolizumab-in-combination-with-bevacizumab-07419.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/rcc/a-study-of-immune-checkpoint-inhibitor-combinations-wit-47221.html2025-03-11https://genentech-clinicaltrials.com/en/trials/cancer/rcc/basket-study-of-entrectinib--rxdx-101--for-the-treatment-of-pati.html2026-01-09https://genentech-clinicaltrials.com/en/trials/cancer/skin-cancer/cobimetinib--targeted-therapy--plus-atezolizumab--immunotherapy-.html2024-06-22https://genentech-clinicaltrials.com/en/trials/cancer/skin-cancer/a-study-of-atezolizumab-plus-cobimetinib-and-vemurafenib-versus-.html2024-10-02https://genentech-clinicaltrials.com/en/trials/cancer/skin-cancer/a-study-evaluating-the-safety-and-efficacy-of-cobimetin-52731.html2024-06-21https://genentech-clinicaltrials.com/en/trials/cancer/skin-cancer/a-study-to-evaluate-the-efficacy-and-safety-of-ro719845-83921.html2025-02-08https://genentech-clinicaltrials.com/en/trials/cancer/skin-cancer/atezolizumab-in-combination-with-bevacizumab-in-patient-26747.html2024-10-25https://genentech-clinicaltrials.com/en/trials/cancer/skin-cancer/a-phase-ib-study-to-evaluate-safety-and-therapeutic-act-73518.html2024-10-04https://genentech-clinicaltrials.com/en/trials/cancer/skin-cancer/a-study-comparing-vemurafenib-versus-vemurafenib-plus-c-99807.html2024-06-21https://genentech-clinicaltrials.com/en/trials/cancer/skin-cancer/a-study-of-ro7293583-in-participants-with-unresectable--00455.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/skin-cancer/a-study-to-evaluate-the-safety-and-activity-of-belvaraf-22554.html2026-01-01https://genentech-clinicaltrials.com/en/trials/cancer/skin-cancer/a-study-of-multiple-doses-of-ro7247669-in-participants--81417.html2026-02-05https://genentech-clinicaltrials.com/en/trials/cancer/hepatocellular-carcinoma/a-study-of-atezolizumab-in-combination-with-bevacizumab-compared.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/hepatocellular-carcinoma/a-phase-i-study-evaluating-safety--pharmacokinetics--ph-52519.html2024-12-10https://genentech-clinicaltrials.com/en/trials/cancer/hepatocellular-carcinoma/a-study-of-atezolizumab--tecentriq--in-combination-with-89929.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/hepatocellular-carcinoma/a-study-of-tace-combined-with-atezolizumab-plus-bevaciz-69738.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/hepatocellular-carcinoma/a-study-of-atezolizumab-in-combination-with-bevacizumab-40482.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/hepatocellular-carcinoma/a-study-of-atezolizumab-with-lenvatinib-or-sorafenib-ve-22252.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/hepatocellular-carcinoma/a-study-evaluating-atezolizumab-and-bevacizumab--with-o-66135.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/hepatocellular-carcinoma/a-study-evaluating-the-efficacy-and-safety-of-neoadjuva-03473.html2025-12-12https://genentech-clinicaltrials.com/en/trials/cancer/hepatocellular-carcinoma/a-study-evaluating-atezolizumab--with-or-without-bevaci-04540.html2025-06-03https://genentech-clinicaltrials.com/en/trials/cancer/Head_and_Neck_Cancer/a-study-of-atezolizumab--antipd-l1-antibody--as-adjuvant-therapy.html2024-10-10https://genentech-clinicaltrials.com/en/trials/cancer/Head_and_Neck_Cancer/a-study-of-atezolizumab-plus-tiragolumab-and-atezolizum-41714.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/Head_and_Neck_Cancer/a-study-of-ro7121661-and-ro7247669-compared-with-nivolu-07266.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/Head_and_Neck_Cancer/a-study-evaluating-efficacy-and-safety-of-multiple-trea-03936.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/Head_and_Neck_Cancer/a-study-to-evaluate-the-safety--pharmacokinetics--and-a-13288.html2025-12-12https://genentech-clinicaltrials.com/en/trials/cancer/study-to-evaluate-the-therapeutic-activity-of-ro6874281-as-a-com.html2025-12-15https://genentech-clinicaltrials.com/en/trials/cancer/Brain_Tumor/study-of-rxdx-101-in-children-with-recurrent-or-refractory-solid.html2025-07-04https://genentech-clinicaltrials.com/en/trials/cancer/Brain_Tumor/a-study-evaluating-the-safety--pharmacokinetics--and-ef-29617.html2026-01-07https://genentech-clinicaltrials.com/en/trials/cancer/pancreatic-cancer/a-study-of-multiple-immunotherapy-based-treatment-combinations-i2.html2025-02-07https://genentech-clinicaltrials.com/en/trials/cancer/pancreatic-cancer/a-study-of-the-efficacy-and-safety-of-adjuvant-autogene-61203.html2025-04-17https://genentech-clinicaltrials.com/en/trials/cancer/pancreatic-cancer/a-study-to-evaluate-the-safety--pharmacokinetics--and-a-49601.html2026-02-03https://genentech-clinicaltrials.com/en/trials/cancer/my-pathway--a-study-evaluating-herceptin-perjeta--tarceva--zelbo.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/a-study-to-investigate-the-efficacy-and-safety-of-cobimetinib-pl.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/a-phase-ii-randomized-study-comparing-the-efficacy-and-safety-of.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/an-extension--rollover--study-of-vemurafenib-in-participants-wit.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/safety-and-pharmacokinetics-of-cobimetinib-in-pediatric-and-youn.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/safety-and-pharmacokinetics--pk--of-escalating-doses-of-mtig7192.html2024-12-06https://genentech-clinicaltrials.com/en/trials/cancer/prostate-cancer/a-study-of-atezolizumab--anti-pd-l1-antibody--in-combination-wit.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/prostate-cancer/ipatasertib-plus-abiraterone-plus-prednisone-prednisolone--relat.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/prostate-cancer/safety-and-tolerability-of-atezolizumab--atz--in-combin-41710.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/prostate-cancer/a-study-evaluating-the-safety--efficacy-and-pharmacokin-79210.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/prostate-cancer/a-study-evaluating-the-safety--pharmacokinetics--and-ac-41296.html2025-02-06https://genentech-clinicaltrials.com/en/trials/cancer/prostate-cancer/castration-resistant-prostate-cancer/a-study-to-test-inavolisib-treatment-in-participants-wi-62424.html2025-12-30https://genentech-clinicaltrials.com/en/trials/cancer/gc/a-study-to-explore-the-efficacy-and-safety-of-atezolizu-61045.html2024-11-15https://genentech-clinicaltrials.com/en/trials/cancer/a-study-of-atezolizumab-in-locally-advanced-or-metastat-72736.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/an-extension-study-to-provide-continued-bevacizumab-therapy-to-p.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-of-atezolizumab-in-combination-with-either-obin-92178.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-trial-of-mosunetuzumab--btct4465a--as-consolidation-t-47718.html2025-04-04https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-the-safety-and-efficacy-of-atezolizu-37082.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/an-open-label--single-arm-study-of-obinutuzumab-short-d-96747.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-the-safety-and-efficacy-of-polatuzu-71789.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-the-efficacy-and-safety-of-polatuzu-85981.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-the-safety--pharmacokinetics--and-ef-94381.html2025-02-12https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-comparing-maintenance-subcutaneous-rituximab-wi-80076.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-the-safety--pharmacokinetics-and-pr-54653.html2025-03-25https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-the-safety-and-efficacy-of-ro7082859-57995.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/an-open-label-phase-lb-study-of-ro7082859-and-atezolizumab-in-ad.html2025-04-12https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-the-safety-and-efficacy-of-mosunetu-47106.html2025-02-25https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-of-ro7082859-in-combination-with-rituximab-or-obinutuzum.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-of-obinutuzumab--rituximab--polatuzumab-vedotin--and-ven.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-of-obinutuzumab--polatuzumab-vedotin--and-lenalidomide-i.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-comparing-the-efficacy-and-safety-of-polatuzumab-vedotin.html2025-07-04https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-phase-ib-ii-study-investigating-the-safety--tolerabil-91932.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-dose-escalation-study-of-ro7082859-as-a-single-agent-and-in-co.html2025-08-18https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-of-escalating-doses-of-dcds0780a-in-participant-05985.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-phase-iii-study-evaluating-glofitamab-in-combination--62070.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-the-safety--efficacy-and-pharmacokin-79640.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-glofitamab-as-single-agent-administ-82920.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-the-efficacy-and-safety-of-mosunetuz-89423.html2026-02-02https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-the-safety--efficacy-and-pharmacokin-19491.html2024-07-12https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-the-safety-and-efficacy-of-glofitam-14259.html2025-02-27https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-efficacy-and-safety-of-mosunetuzumab-27695.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-the-safety--pharmacokinetics--and-ef-62272.html2025-01-11https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-the-safety--tolerability--pharmacok-73268.html2024-07-25https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-the-safety--efficacy--and-pharmacoki-74363.html2025-03-13https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/an-open-label--multicenter-study-evaluating-the-safety--95093.html2024-10-05https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-the-efficacy--safety--and-pharmacoki-00365.html2025-03-19https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-of-gdc-0853-in-patients-with-resistant-b-cell-l-94923.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-glofitamab---chemoimmunotherapy-in--23052.html2025-02-24https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/an-open-label-study-comparing-glofitamab-and-polatuzuma-51322.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-glofitamab-as-a-single-agent-vs--in-75996.html2025-03-08https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-evaluating-the-safety-and-efficacy-of-glofitama-69902.html2025-03-07https://genentech-clinicaltrials.com/en/trials/cancer/non-hodgkins-lymphoma/a-study-to-evaluate-the-optimization-of-the-cytokine-re-47603.html2026-01-23https://genentech-clinicaltrials.com/en/trials/cancer/a-study-of-the-safety--pharmacokinetics--and-therapeuti-98047.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/a-study-in-patients-previously-enrolled-in-a-genentech--39726.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/a-dose-escalation-and-expansion-study-of-ro7121661--a-p-10103.html2024-08-29https://genentech-clinicaltrials.com/en/trials/cancer/endometrial-cancer/a-study-of-giredestrant-in-participants-with-grade-1-en-08530.html2025-08-29https://genentech-clinicaltrials.com/en/trials/cancer/a-study-evaluating-the-safety--tolerability--pharmacoki-00443.html2024-12-21https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/an-open-label-dose-escalation-study-to-evaluate-xmab243-88679.html2025-01-28https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-the-safety--tolerability--pharmacok-12037.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-safety-and-anti-tumor-activity-of-r-73278.html2025-03-06https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-the-safety-and-tolerability-of-ro72-99201.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-of-the-pharmacokinetics-and-safety-of-ipatasert-33443.html2024-10-29https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-of-gdc-0919-and-atezolizumab-combination-treatm-85004.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-assess-the-safety-and-pharmacokinetics-of-mo-12948.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-of-ro6958688-in-participants-with-locally-advan-08287.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/tumor-agnostic-precision-immuno-oncology-and-somatic-ta-50851.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-evaluating-targeted-therapies-in-participants-w-28698.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-the-safety-and-tolerability-of-ro72-03496.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-safety--pharmacokinetics-and-anti-t-88927.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-of-atezolizumab--an-engineered-anti-programmed--72013.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/rly-1971-in-subjects-with-advanced-or-metastatic-solid--45813.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-assess-safety-and-pharmacokinetics-of-moxr09-56953.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-assess-the-safety-and-tolerability-of-atezol-62655.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-safety--pharmacokinetics--and-preli-17129.html2024-09-01https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/screening-study-for-participants-with-malignant-tumors-95723.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-the-safety--pharmacokinetics--and-a-57671.html2025-03-26https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-the-safety-and-pharmacokinetics-of--11686.html2025-03-11https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-the-safety--pharmacokinetics--and-a-03859.html2025-03-06https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-the-safety--pharmacokinetics--and-a-30655.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-phase-1-study-of-ksq-4279-alone-and-in-combination-in-91417.html2025-02-22https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-of-adjuvant-atezolizumab-or-atezolizumab-plus-t-86863.html2024-12-27https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-of-ro7617991-in-patients-with-locally-advanced--79963.html2024-09-04https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-the-safety--pharmacokinetics--and-a-74947.html2025-03-18https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-safety-and-efficacy-extension-study-of-pertuzumab-in-patients-.html2026-01-22https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-safety--pharmacokinetics--and-activ-16036.html2025-03-07https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-phase-1-trial-of-zn-a-1041-enteric-capsules-or-combin-99630.html2025-09-05https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-study-to-evaluate-the-safety--pharmacokinetics--and-a-80717.html2026-01-15https://genentech-clinicaltrials.com/en/trials/cancer/solid-tumors/a-phase-i-study-of-btrc4017a-in-participants-with-locally-advanc.html2026-02-28https://genentech-clinicaltrials.com/en/trials/cancer/thymic-carcinoma/a-study-to-investigate-the-efficacy-and-safety-of-atezo-65676.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/high-grade-glioma/a-study-of-bevacizumab--avastin--in-combination-with-te-29856.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/esophageal-squamous-cell-carcinoma/a-study-of-atezolizumab-with-or-without-tiragolumab-in--42508.html2025-04-11https://genentech-clinicaltrials.com/en/trials/cancer/esophageal-cancer/a-study-of-atezolizumab-plus-tiragolumab-in-combination-19474.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/melanoma/a-study-evaluating-the-efficacy-and-safety-of-multiple--23342.html2024-08-28https://genentech-clinicaltrials.com/en/trials/cancer/melanoma/dose-escalation-study-of-a-pd1-lag3-bispecific-antibody-65890.html2026-03-19https://genentech-clinicaltrials.com/en/trials/cancer/a-study-of-atezolizumab-with-or-without-bevacizumab-in--17170.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/thyroid-cancer/a-study-of-pralsetinib-versus-standard-of-care--soc--fo-38754.html2024-08-30https://genentech-clinicaltrials.com/en/trials/cancer/thyroid-cancer/phase-1-2-study-of-the-highly-selective-ret-inhibitor---95391.html2024-08-31https://genentech-clinicaltrials.com/en/trials/cancer/rectal-cancer/a-study-of-atezolizumab-with-or-without-tiragolumab-fol-62656.html2024-11-16https://genentech-clinicaltrials.com/en/trials/cancer/gbm/a-study-evaluating-the-safety--pharmacokinetic-and-anti-87611.html2025-03-08https://genentech-clinicaltrials.com/en/trials/cancer/gastric-and-gastroesophageal-junction-carcinoma/an-umbrella-study-evaluating-the-efficacy-and-safety-of-03674.html2025-01-04https://genentech-clinicaltrials.com/en/trials/cancer/gastric-and-gastroesophageal-junction-carcinoma/a-study-of-multiple-immunotherapy-based-treatment-combinations-i1.html2025-12-16https://genentech-clinicaltrials.com/en/trials/cancer/gastric-and-gastroesophageal-junction-carcinoma/a-study-of-atezolizumab-and-trastuzumab-in-combination--37274.html2026-01-31https://genentech-clinicaltrials.com/en/trials/cancer/clinical-impact-and-utility-of-digital-health-solutions-26657.html2025-02-04https://genentech-clinicaltrials.com/en/trials/cancer/a-rollover-study-for-participants-previously-enrolled-i-26392.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/a-study-evaluating-single-agent-inavolisib-and-inavolis-05009.html2025-03-27https://genentech-clinicaltrials.com/en/trials/cancer/a-study-to-evaluate-the-safety--tolerability--processing-by-the-.html2024-12-03https://genentech-clinicaltrials.com/en/trials/cancer/tumor/a-study-to-evaluate-the-safety--tolerability--pharmacok-47960.html2025-03-20https://genentech-clinicaltrials.com/en/trials/cancer/tumor/a-dose-escalation-study-of-ro7567132-as-single-agent-an-91039.html2025-12-19https://genentech-clinicaltrials.com/en/trials/cancer/tumor/neoplasms/a-safety-extension-study-of-trastuzumab-emtansine-in-participant.html2025-12-25https://genentech-clinicaltrials.com/en/trials/cancer/tumor/an-extension-study-in-participants-previously-enrolled--98290.html2026-01-08https://genentech-clinicaltrials.com/en/trials/cancer/tumor/a-roll-over-study-of-alectinib-in-patients-with-anaplastic-lymph.html2026-02-21https://genentech-clinicaltrials.com/en/trials/cancer/tumor/acceleret-lung-study-of-pralsetinib-for-1l-ret-fusion-p-70294.html2026-03-06https://genentech-clinicaltrials.com/en/trials/cancer/gastrointestinal-cancer/a-study-to-evaluate-the-impact-of-liquid-biopsy-in-part-68268.html2025-12-18https://genentech-clinicaltrials.com/en/trials/cancer/advanced-liver-cancers/a-study-evaluating-the-efficacy-and-safety-of-multiple--09597.html2026-01-08https://genentech-clinicaltrials.com/en/trials/cancer/Oncology/a-study-to-evaluate-the-efficacy-and-safety-of-giredest-09790.html2026-01-17https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/jia/a-study-of-decreased-dose-frequency-in-participants-with-systemi.html2024-08-30https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/jia/a-study-of-tocilizumab-in-chinese-participants-with-systemic-juv.html2024-06-22https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/jia/a-study-of-subcutaneously--sc--administered-tocilizumab-80633.html2024-06-22https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/jia/a-study-of-subcutaneously-administered-tocilizumab-in-p-36947.html2024-06-22https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ra/a-study-to-evaluate-the-long-term-safety-and-efficacy-of-gdc-085.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ra/study-to-compare-the-efficacy-of-tocilizumab-with-or-without-glu.html2024-08-30https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ra/a-study-to-assess-the-efficacy-and-safety-of-ro7790121--26837.html2025-12-18https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ulcerative-colitis/a-phase-i-study-of-etrolizumab-followed-by-open-label-extension-.html2024-12-28https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ulcerative-colitis/a-safety-study-of-intravenously-administered-uttr1147a-in-health.html2024-06-22https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ulcerative-colitis/a-study-comparing-the-efficacy-and-safety-of-etrolizumab-to-infl.html2024-09-01https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ulcerative-colitis/a-study-comparing-the-efficacy-and-safety-of-etrolizumab-with-ad.html2024-09-24https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ulcerative-colitis/a-study-of-the-efficacy-and-safety-of-etrolizumab-in-ulcerative-.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ulcerative-colitis/a-study-to-evaluate-the-efficacy--safety--and-pharmacokinetics-o.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ulcerative-colitis/study-for-participants-with-ulcerative-colitis-previously-enroll.html2024-10-24https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ulcerative-colitis/a-study-of-the-efficacy-and-safety-of-etrolizumab-treatment-in-m.html2024-08-30https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ulcerative-colitis/an-extension-study-to-evaluate-the-long-term-safety-and-37359.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ulcerative-colitis/a-study-comparing-the-efficacy-and-safety-of-etrolizumab-with-ad0.html2024-09-24https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ulcerative-colitis/a-study-to-evaluate-the-safety--tolerability--processing-by-the-.html2022-04-22https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/crohn-s-disease/a-study-to-assess-whether-etrolizumab-is-a-safe-and-effective-tr.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/crohn-s-disease/open-label-extension-and-safety-study-for-patients-with-crohn-s-.html2024-12-03https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/crohn-s-disease/rvt-3101-for-the-treatment-of-moderate-to-severe-active-94909.html2024-12-28https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/crohn-s-disease/a-study-to-assess-the-efficacy-and-safety-of-induction--94939.html2025-05-26https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/crohn-s-disease/a-study-to-assess-the-efficacy-and-safety-of-induction--32899.html2025-05-26https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/sle/study-of-the-safety-and-efficacy-of-gdc-0853-in-participants-wit.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/sle/a-study-to-evaluate-the-efficacy-and-safety-of-obinutuz-62318.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/sle/a-study-to-evaluate-the-safety--tolerability--pharmacok-87119.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/sle/a-first-in-human-study-to-investigate-the-safety--toler-46873.html2025-11-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/sle/a-study-to-evaluate-the-safety--tolerability--cellular--19328.html2025-05-23https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/an-extension-study-of-gdc-0853-in-participants-with-moderate-to-.html2024-08-30https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/a-study-to-assess-the-efficacy-and-safety-of-mstt1041a--54098.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/systemic-sclerosis/a-study-to-evaluate-the-safety--tolerability--and-pharm-79881.html2025-01-23https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ibd/a-study-to-evaluate-the-efficacy--safety--and-pharmacok-50752.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ibd/a-study-to-assess-the-efficacy-and-safety-of-ro7790121--09855.html2025-07-16https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ibd/a-study-to-assess-the-efficacy-and-safety-of-induction--79083.html2025-07-16https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ibd/a-study-to-evaluate-the-activity--and-safety-of-vixarel-16448.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ibd/a-study-to-evaluate-the-efficacy--safety--and-pharmacok-27348.html2025-05-20https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ibd/ulcerative-colitis/a-study-to-evaluate-the-pharmacokinetics--safety-and-ef-90470.html2025-09-10https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/gpa/a-phase-iia-study-of-intravenous-rituximab-in-pediatric-00800.html2024-06-21https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/a-study-to-evaluate-the-efficacy-and-safety-of-rituxima-33498.html2024-09-01https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ln/a-study-to-evaluate-the-efficacy-and-safety-of-obinutuz-33293.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ln/a-study-to-evaluate-the-safety-and-efficacy-of-obinutuz-72984.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/ln/a-study-to-evaluate-the-efficacy--safety--and-pharmacok-25573.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/neuromyelitis-optica-spectrum-disorders/efficacy-and-safety-study-of-satralizumab--sa237--as-mo-50688.html2024-09-01https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/neuromyelitis-optica-spectrum-disorders/efficacy-and-safety-study-of-satralizumab--sa237--as-ad-86851.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/neuromyelitis-optica-spectrum-disorders/a-study-to-evaluate-the-safety-and-efficacy-of-satraliz-27030.html2024-08-30https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/neuromyelitis-optica-spectrum-disorders/a-study-to-evaluate-pharmacokinetics--efficacy--safety--09121.html2025-01-04https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/neuromyelitis-optica-spectrum-disorders/a-study-in-neuromyelitis-optica-spectrum-disorder--nmos-38791.html2025-01-23https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/pnh/a-study-evaluating-the-efficacy-and-safety-of-crovalima-16124.html2025-02-12https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/pnh/a-phase-iii-study-evaluating-the-efficacy-and-safety-of-15078.html2025-02-08https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/pnh/a-study-evaluating-the-efficacy--safety--pharmacokineti-79495.html2025-03-14https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/pnh/study-to-assess-safety--efficacy--pharmacokinetics--and-pharmaco.html2026-02-18https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/myasthenia-gravis-iab/a-study-to-evaluate-efficacy--safety--pharmacokinetics--13414.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/mog-antibody-disease/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-94806.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/autoimmune-encephalitis/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-99237.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/guillain-barre-syndrome/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-89106.html2024-06-21https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/a-clinical-trial-of-omalizumab-in-participants-with-chronic-rhin.html2024-09-24https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/a-clinical-trial-of-omalizumab-in-participants-with-chronic-rhin0.html2024-09-24https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/an-extension-study-of-omalizumab-in-participants-with-chronic-rh.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/study-to-evaluate-the-effectiveness-and-safety-of-ocrelizumab-in.html2025-01-16https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/this-is-an-extension-study-of-the-roche-p-trial-to-inve-91061.html2024-11-08https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-the-safety-of-administering-ocreliz-75757.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-ocrelizumab-treatment-in-participants-with-p.html2025-12-11https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/study-to-explore-the-mechanism-of-action-of-ocrelizumab-and-b-ce.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-of-ocrelizumab-in-participants-with-relapsing-r-56554.html2024-08-31https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-investigate-the-pharmacokinetics--safety--an-81373.html2025-03-25https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-of-ocrelizumab-in-children-and-adolescents-with-52808.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-the-efficacy-and-safety-of-ocrelizu-22490.html2025-01-28https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/study-to-assess-disease-activity-and-biomarkers-in-mino-64910.html2025-01-25https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-the-effects-of-ocrelizumab-on-immun-95763.html2024-08-30https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-the-efficacy--safety-and-pharmacoki-23163.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-the-efficacy-and-safety-of-fenebrut-03470.html2025-03-26https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-the-efficacy--safety-and-pharmacoki-18428.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-the-efficacy-and-safety-of-fenebrut-75978.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/study-to-evaluate-the-efficacy-and-safety-of-fenebrutin-78378.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-evaluating-b-cell-levels-in-infants-potentially-32501.html2024-11-08https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-evaluating-b-cell-levels-in-infants-of-lactatin-77086.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-investigate-the-efficacy-of-fenebrutinib-in--90400.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-safety-and-efficacy-of-ocrelizumab--72268.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-determine-the-effect-of-ocrelizumab-on-lepto-37864.html2024-08-30https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-phase-iii--non-inferiority--randomized--open-label--p-91560.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-rollover-study-to-evaluate-the-long-term-safety-and-e-52490.html2025-03-27https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-investigate-the-safety--tolerability--and-pr-15846.html2025-03-26https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/an-extension-study-to-assess-impact-of-multiple-scleros-77372.html2026-01-13https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-of-the-efficacy-and-safety-of-ocrelizumab-in-pa-79516.html2025-03-10https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-the-safety--tolerability--cellular--79566.html2025-09-17https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-assess-bioequivalence-of-two-subcutaneous--s-18385.html2025-07-28https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-pharmacokinetics--pk---pharmacodynamics--pd---safety--83549.html2025-12-12https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-the-safety--pharmacokinetics--pharm-05385.html2026-01-14https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/multiple-sclerosis/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-43360.html2026-03-25https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/atopic-dermatitis/a-study-to-assess-the-efficacy-and-safety-of-ro7790121--62648.html2025-06-06https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/atopic-dermatitis/a-long-term-extension-study-to-evaluate-the-safety-and--63775.html2025-11-04https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/antiphospholipid-syndrome/a-study-to-evaluate-crovalimab-in-people-with-antiphosp-40584.html2025-09-19https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/mn/a-study-evaluating-the-efficacy-and-safety-of-obinutuzu-42023.html2025-12-18https://genentech-clinicaltrials.com/en/trials/autoimmune-disorder/a-study-to-assess-the-pharmacokinetics--effectiveness-a-60433.html2026-02-21https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/a-study-of-ro6867461-in-participants-with-center-involving-diabe.html2024-08-30https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/a-study-to-evaluate-the-efficacy-and-safety-of-ro686746-59371.html2024-09-24https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/this-study-will-evaluate-the-efficacy--safety--and-phar-29878.html2026-02-05https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/a-study-to-evaluate-the-long-term-safety-and-tolerabili-41480.html2024-10-31https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/a-study-to-investigate-aqueous-humor-and-multimodal-ima-93975.html2024-08-30https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/a-study-to-investigate-ro7200220-in-combination-with-ra-51781.html2025-02-06https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/a-study-to-investigate-ro7200220-in-diabetic-macular-ed-90636.html2025-03-27https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/a-study-to-investigate-faricimab-treatment-response-in--30867.html2025-03-08https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/a-study-to-investigate-ro7200220-as-monotherapy-and-in--79234.html2025-01-14https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/a-study-to-investigate-the-safety--tolerability--pharma-00389.html2026-01-13https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/a-study-to-evaluate-the-safety--tolerability--pharmacok-19095.html2025-03-29https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/a-study-conducted-to-evaluate-the-conjunctiva-and-tenon-69281.html2025-12-13https://genentech-clinicaltrials.com/en/trials/eye-disorder/dme/a-study-to-evaluate-the-safety--tolerability--pharmacod-21453.html2026-02-24https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/safety-and-tolerability-study-of-ro7171009-in-participants-with-.html2024-08-31https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/a-phase-iii-study-to-evaluate-the-port-delivery-system--47798.html2024-08-31https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/study-to-evaluate-ro6867461--rg7716--for-extended-durability-in-.html2024-08-31https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/extension-study-for-the-port-delivery-system-with-ranib-90123.html2025-03-27https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/a-study-assessing-the-safety--tolerability--and-efficac-97970.html2024-08-31https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/study-of-the-efficacy-and-safety-of-the-ranibizumab-por-72656.html2024-08-30https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/a-study-assessing-the-long-term-safety-and-tolerability-81852.html2024-08-31https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/a-study-to-evaluate-the-safety--tolerability--pharmacok-30793.html2024-08-30https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/a-study-of-the-efficacy--safety--and-pharmacokinetics-o-88020.html2025-03-27https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/a-study-to-evaluate-the-long-term-safety-and-tolerabili-60381.html2024-12-12https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/a-proof-of-concept-study-of-faricimab--ro6867461--in-pa-45643.html2024-08-30https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/a-study-of-the-effectiveness-and-safety-of-a-36-week-re-51734.html2024-08-30https://genentech-clinicaltrials.com/en/trials/eye-disorder/amd/an-observational-study-of-the-progression-of-intermedia-82147.html2025-03-27https://genentech-clinicaltrials.com/en/trials/eye-disorder/wamd/a-study-to-evaluate-the-efficacy-and-safety-of-faricima-34628.html2024-08-30https://genentech-clinicaltrials.com/en/trials/eye-disorder/wamd/a-study-to-evaluate-the-efficacy-and-safety-of-faricima-82370.html2024-09-01https://genentech-clinicaltrials.com/en/trials/eye-disorder/wamd/a-study-of-36-week-refill-exchanges-of-port-delivery-sy-66037.html2025-02-27https://genentech-clinicaltrials.com/en/trials/eye-disorder/rvo/a-study-to-evaluate-the-efficacy-and-safety-of-faricima-25491.html2024-08-31https://genentech-clinicaltrials.com/en/trials/eye-disorder/rvo/a-study-to-evaluate-the-efficacy-and-safety-of-faricima-34453.html2024-08-31https://genentech-clinicaltrials.com/en/trials/eye-disorder/rvo/a-real-world-study-to-gain-clinical-insights-into-roche-45751.html2025-12-23https://genentech-clinicaltrials.com/en/trials/eye-disorder/neovascular-age-related-macular-degeneration/a-study-of-the-efficacy--safety--and-pharmacokinetics-o-85124.html2025-03-27https://genentech-clinicaltrials.com/en/trials/eye-disorder/neovascular-age-related-macular-degeneration/a-study-to-determine-the-efficacy--safety--and-durabili-18839.html2025-07-04https://genentech-clinicaltrials.com/en/trials/eye-disorder/neovascular-age-related-macular-degeneration/a-study-of-the-efficacy-and-safety-of-the-port-delivery-66961.html2026-02-14https://genentech-clinicaltrials.com/en/trials/eye-disorder/damd/a-study-to-optimize-subretinal-surgical-delivery-and-to-78638.html2025-03-29https://genentech-clinicaltrials.com/en/trials/eye-disorder/damd/a-study-to-investigate-safety--tolerability--pharmacoki-32726.html2025-05-08https://genentech-clinicaltrials.com/en/trials/eye-disorder/uveitic-macular-edema/a-study-to-investigate-ro7200220-in-participants-with-u-27483.html2025-11-22https://genentech-clinicaltrials.com/en/trials/eye-disorder/uveitic-macular-edema/ro7200220-in-participants-with-uveitic-macular-edema-91001.html2026-01-22https://genentech-clinicaltrials.com/en/trials/eye-disorder/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-83677.html2026-02-18https://genentech-clinicaltrials.com/en/trials/eye-disorder/thyroid-eye-disease/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-16079.html2025-05-20https://genentech-clinicaltrials.com/en/trials/eye-disorder/dry-eye-syndrome/a-study-to-explore-signs--symptoms--and-biomarkers-in-d-63318.html2025-07-17https://genentech-clinicaltrials.com/en/trials/eye-disorder/choroidal-neovascularization/a-study-to-evaluate-the-efficacy-and-safety-of-faricima-11547.html2025-12-27https://genentech-clinicaltrials.com/en/trials/eye-disorder/macular-degeneration/study-of-ro7250284-in-participants-with-neovascular-age-53349.html2026-01-13https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/sma/a-study-of-ro7034067-in-adult-and-pediatric-participants-with-sp.html2025-02-25https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/sma/a-study-to-investigate-the-safety--tolerability--pharmacokinetic1.html2024-08-31https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/sma/investigate-safety--tolerability--pk--pd-and-efficacy-of-ro70340.html2024-08-30https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/sma/a-study-of-risdiplam-in-infants-with-genetically-diagno-31840.html2025-03-27https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/sma/bioavailability-and-bioequivalence-of-two-risdiplam-tab-67663.html2024-08-31https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/sma/a-study-to-investigate-the-safety-and-efficacy-of-ro720-92328.html2025-03-25https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/sma/long-term-follow-up-study-of-risdiplam-in-participants--98047.html2025-03-07https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/sma/a-study-to-investigate-the-pharmacokinetics-and-safety--67639.html2025-03-04https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/sma/a-study-evaluating-the-effectiveness-and-safety-of-risd-84354.html2026-03-27https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/sma/a-study-evaluating-the-effectiveness-and-safety-of-risd-44908.html2026-03-26https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/sma/an-observational-study-to-look-at-the-effects-of-evrysdi--risdip.html2024-06-28https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/dmd/clinical-trial-to-evaluate-the-efficacy--safety--and-to-14306.html2024-08-31https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/dmd/systemic-gene-delivery-clinical-trial-for-duchenne-musc-40014.html2024-11-19https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/dmd/a-gene-delivery-study-to-evaluate-the-safety-and-expres-58068.html2025-02-19https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/dmd/an-open-label-study-to-assess-the-efficacy-and-safety-o-12382.html2025-03-08https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/muscular-dystrophy/study-of-an-investigational-drug--ro7239361--bms-986089-96144.html2024-08-31https://genentech-clinicaltrials.com/en/trials/muscle-and-peripheral-nerve-disease/facioscapulohumeral-muscular-dystrophy/a-study-to-evaluate-ro7204239-in-participants-with-faci-44329.html2024-03-21https://genentech-clinicaltrials.com/en/trials/infectious-diseases/hbv/a-study-to-investigate-the-safety--tolerability--pharmacokinetic2.html2024-11-01https://genentech-clinicaltrials.com/en/trials/infectious-diseases/hbv/a-study-in-healthy-volunteers-and-in-participants-with-chronic-h.html2024-09-01https://genentech-clinicaltrials.com/en/trials/infectious-diseases/hbv/a-trial-to-evaluate-the-efficacy-and-safety-of-multiple-42976.html2024-08-31https://genentech-clinicaltrials.com/en/trials/infectious-diseases/hbv/a-study-of-pegylated-interferon-alfa-2a-in-combination-with-lami.html2024-08-31https://genentech-clinicaltrials.com/en/trials/infectious-diseases/influenza/study-to-assess-the-safety--pharmacokinetics--and-effic-62594.html2024-06-22https://genentech-clinicaltrials.com/en/trials/infectious-diseases/influenza/study-to-assess-efficacy-and-safety-of-baloxavir-marbox-94137.html2024-09-01https://genentech-clinicaltrials.com/en/trials/infectious-diseases/influenza/study-to-assess-the-efficacy-of-baloxavir-marboxil-vers-02272.html2024-09-01https://genentech-clinicaltrials.com/en/trials/infectious-diseases/influenza/a-surveillance-study-of-susceptibility-to-baloxavir-mar-15550.html2025-02-19https://genentech-clinicaltrials.com/en/trials/infectious-diseases/influenza/study-to-assess-the-safety--pharmacokinetics--and-effic-15352.html2025-03-27https://genentech-clinicaltrials.com/en/trials/infectious-diseases/bacterial-infection/study-to-investigate-the-safety--tolerability--and-pharmacokinet.html2024-08-31https://genentech-clinicaltrials.com/en/trials/infectious-diseases/bacterial-infection/a-study-to-investigate-the-pharmacokinetics-of-ro722328-97260.html2024-08-30https://genentech-clinicaltrials.com/en/trials/infectious-diseases/efficacy-and-safety-of-gdc-0853-in-participants-with-refractory-.html2024-08-30https://genentech-clinicaltrials.com/en/trials/infectious-diseases/a-study-to-evaluate-the-long-term-safety-and-efficacy-o-90506.html2024-08-31https://genentech-clinicaltrials.com/en/trials/infectious-diseases/covid-19-pneumonia/a-study-to-investigate-intravenous-tocilizumab-in-parti-82314.html2024-08-31https://genentech-clinicaltrials.com/en/trials/infectious-diseases/covid-19-pneumonia/a-study-to-evaluate-the-efficacy-and-safety-of-tocilizu-42486.html2024-08-30https://genentech-clinicaltrials.com/en/trials/infectious-diseases/covid-19-pneumonia/a-study-to-evaluate-the-safety-and-efficacy-of-mstt1041-69681.html2024-09-01https://genentech-clinicaltrials.com/en/trials/infectious-diseases/covid-19-pneumonia/study-to-evaluate-the-effects-of-at-527-in-non-hospital-29576.html2024-08-30https://genentech-clinicaltrials.com/en/trials/infectious-diseases/covid-19-pneumonia/study-to-evaluate-the-effects-of-ro7496998--at-527--in--47025.html2024-08-31https://genentech-clinicaltrials.com/en/trials/infectious-diseases/covid-19-pneumonia/a-six-month-follow-up-study-of-participants-with-corona-57262.html2024-08-30https://genentech-clinicaltrials.com/en/trials/infectious-diseases/covid-19-pneumonia/a-study-evaluating-tocilizumab-in-pediatric-patients-ho-36781.html2024-08-31https://genentech-clinicaltrials.com/en/trials/infectious-diseases/chronic-hepatitis-b/a-study-to-investigate-safety--tolerability--pharmacoki-69796.html2025-03-27https://genentech-clinicaltrials.com/en/trials/infectious-diseases/mycosis/systemic-mycosis/candidiasis/performance-study-of-the-cobas--bv-cv-test-on-samples-f-38531.html2025-05-22https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-of-crenezumab-versus-placebo-to-evaluate-the-efficacy-an.html2024-09-01https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-to-evaluate-the-efficacy-and-safety-of-ro7105705-in-pati.html2024-08-31https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/safety-and-efficacy-study-of-gantenerumab-in-participants-with-e.html2024-06-22https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/efficacy-and-safety-study-of-gantenerumab-in-participants-with-e.html2024-08-30https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/cread-study--a-study-of-crenezumab-versus-placebo-to-ev-21662.html2024-08-31https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-of-mtau9937a-in-patients-with-moderate-alzheime-94595.html2024-10-01https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-of-gantenerumab-in-participants-with-mild-alzhe-16675.html2024-06-22https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-of-gantenerumab-in-participants-with-prodromal--48625.html2024-08-31https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-to-evaluate-the-safety-and-tolerability-of-long-88018.html2024-08-31https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-to-evaluate-the-safety--tolerability--and-effic-66535.html2024-08-31https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/evaluation-comparing-two-tau-pet-radiotracers---18f-pi--90861.html2024-12-06https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-to-evaluate-the-pharmacodynamic--pd--effects-of-20860.html2025-12-31https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/brainshuttle-ad--a-multiple-ascending-dose-study-to-inv-79871.html2025-03-08https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-of-crenezumab-in-participants-with-mild-to-mode-97085.html2024-08-31https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-to-evaluate-the-efficacy-and-safety-of-gantener-84528.html2024-08-30https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-to-evaluate-the-safety-and-biomarker-effects-of-20108.html2025-03-27https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-of-crenezumab-versus-placebo-in-preclinical-pre-27039.html2025-02-19https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-clinical-trial-of-trontinemab-in-participants-with-ea-85398.html2025-12-30https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-of-trontinemab-in-participants-with-early-sympt-02194.html2026-03-06https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/screening-study-to-determine-individuals-with-potential-76396.html2025-09-18https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/ad/a-study-to-investigate-the-safety--tolerability--pharma-49470.html2025-11-20https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/als/a-study-of-gdc-0134-to-determine-initial-safety--tolerability--a.html2024-08-31https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/pd/a-study-to-evaluate-the-efficacy-and-safety-of-intraven-35605.html2025-01-22https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/pd/a-study-to-investigate-the-safety--tolerability--pharma-25036.html2024-09-20https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/pd/a-study-to-evaluate-the-efficacy-and-safety-of-intraven-34007.html2025-11-13https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/pd/a-study-to-evaluate-the-efficacy-of-ro7046015-in-participants-wi.html2026-01-30https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/hd/a-study-to-evaluate-the-efficacy-and-safety-of-intrathe-26435.html2025-05-08https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/hd/study-to-measure-cerebrospinal-fluid-mutant-huntingtin--30045.html2025-01-04https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/hd/study-in-huntington-s-disease-patients-who-participated-34698.html2024-08-30https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/hd/an-open-label-extension-study-to-evaluate-the-long-term-82935.html2024-08-31https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/hd/a-study-to-investigate-the-pharmacokinetics-and-pharmac-82253.html2024-10-04https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/hd/a-study-to-evaluate-the-safety--biomarkers--and-efficac-41200.html2026-01-16https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/hd/frequency-of-selected-single-nucleotide-polymorphisms-i-91631.html2025-09-10https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/hd/a-study-to-evaluate-the-safety--tolerability--pharmacok-91830.html2025-12-29https://genentech-clinicaltrials.com/en/trials/neurodegenerative-disorder/hd/a-randomized-study-of-spk-10001-gene-therapy-in-partici-27140.html2025-12-18https://genentech-clinicaltrials.com/en/trials/neurodevelopmental-disorder/autism-spectrum-disorder/a-study-of-balovaptan-in-adults-with-autism-spectrum-disorder-wi.html2024-06-21https://genentech-clinicaltrials.com/en/trials/neurodevelopmental-disorder/autism-spectrum-disorder/a-study-to-investigate-the-efficacy-and-safety-of-ro5285119-in-p.html2024-08-30https://genentech-clinicaltrials.com/en/trials/neurodevelopmental-disorder/autism-spectrum-disorder/a-study-to-investigate-the-safety--tolerability--pharma-64337.html2024-08-31https://genentech-clinicaltrials.com/en/trials/neurodevelopmental-disorder/autism-spectrum-disorder/the-effect-of-hepatic-impairment-on-the-pharmacokinetic-77498.html2024-09-01https://genentech-clinicaltrials.com/en/trials/neurodevelopmental-disorder/autism/a-12-week-placebo-controlled-study-to-investigate-the-e-88629.html2025-01-29https://genentech-clinicaltrials.com/en/trials/neurodevelopmental-disorder/angelman-syndrome/a-study-to-investigate-the-safety--tolerability--pharma-19556.html2026-01-23https://genentech-clinicaltrials.com/en/trials/neurodevelopmental-disorder/angelman-syndrome/a-study-to-assess-distribution-of-ro7248824-in-the-cent-71322.html2024-06-22https://genentech-clinicaltrials.com/en/trials/neurodevelopmental-disorder/angelman-syndrome/study-to-investigate-the-pharmacokinetics-and-safety-an-84203.html2025-12-05https://genentech-clinicaltrials.com/en/trials/neurodevelopmental-disorder/a-study-to-investigate-the-effect-of-enzyme-inhibition-on-the-bo.html2022-04-22https://genentech-clinicaltrials.com/en/trials/neurodevelopmental-disorder/dup15q-syndrome/a-study-to-evaluate-the-safety-and-efficacy-of-basmisan-98150.html2024-06-22https://genentech-clinicaltrials.com/en/trials/psychiatric-disorder/schizophrenia/a-study-to-assess-the-effects-of-ro6889450-in-participa-51328.html2024-08-13https://genentech-clinicaltrials.com/en/trials/psychiatric-disorder/schizophrenia/a-trial-of-the-efficacy-and-the-safety-of-ro6889450-vs--91788.html2024-06-22https://genentech-clinicaltrials.com/en/trials/psychiatric-disorder/schizophrenia/a-study-to-evaluate-the-safety--tolerability--processing-by-the-.html2022-04-22https://genentech-clinicaltrials.com/en/trials/psychiatric-disorder/ptsd/study-to-evaluate-the-efficacy-and-safety-of-balovaptan-98241.html2024-06-05https://genentech-clinicaltrials.com/en/trials/respiratory-disorder/ipf/a-study-to-characterize-the-disease-behavior-of-idiopathic-pulmo.html2024-08-30https://genentech-clinicaltrials.com/en/trials/respiratory-disorder/ipf/efficacy--safety--and-tolerability-study-of-pirfenidone-in-combi.html2024-08-31https://genentech-clinicaltrials.com/en/trials/respiratory-disorder/ipf/a-study-evaluating-the-efficacy-and-safety-of-vixarelim-89139.html2025-03-27https://genentech-clinicaltrials.com/en/trials/respiratory-disorder/asthma/a-study-to-assess-the-efficacy-and-safety-of-mstt1041a--35784.html2024-06-21https://genentech-clinicaltrials.com/en/trials/respiratory-disorder/asthma/a-study-to-evaluate-the-efficacy--safety--and-pharmacok-66457.html2024-06-22https://genentech-clinicaltrials.com/en/trials/respiratory-disorder/copd/a-study-of---_xe-mri-to-assess-disease-progression-in-p-99725.html2024-12-27https://genentech-clinicaltrials.com/en/trials/respiratory-disorder/copd/a-study-to-evaluate-the-efficacy-and-safety-of-astegoli-91402.html2025-03-27https://genentech-clinicaltrials.com/en/trials/respiratory-disorder/copd/a-study-to-evaluate-astegolimab-in-participants-with-ch-57511.html2025-06-03https://genentech-clinicaltrials.com/en/trials/respiratory-disorder/copd/a-study-to-evaluate-the-long-term-safety-of-astegolimab-26646.html2025-03-27https://genentech-clinicaltrials.com/en/trials/respiratory-disorder/copd/a-study-to-test-the-safety-and-effects-of-inhaled-gdc-6-20197.html2025-12-18https://genentech-clinicaltrials.com/en/trials/respiratory-disorder/copd/a-copd-data-registry-for-participants-with-frequent-exa-00786.html2025-07-11https://genentech-clinicaltrials.com/en/trials/respiratory-disorder/chronic-refractory-cough-crc/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-62935.html2025-12-17https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-of-the-safety--tolerability--pharmacokinetics-and-pharma.html2024-06-22https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-to-investigate-the-bioequivalence-of-two-differ-55333.html2024-06-21https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-to-determine-the-bioavailability-of-various-for-64037.html2024-06-21https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/evaluation-of-the-relative-bioavailability-and-food-eff-96225.html2024-06-22https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-to-investigate-the-safety--tolerability-and-pha-58683.html2024-08-31https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/study-to-investigate-the-absorption--metabolism--and-ex-28355.html2024-06-22https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-to-investigate-the-processing-by-the-body--safety--and-s.html2022-04-22https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-in-healthy-male-subjects-to-investigate-the-com-31356.html2024-08-31https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/healthy-male-subjects/a-study-to-evaluate-single-subcutaneous-doses-of-nxt007-64666.html2025-03-27https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/healthy-male-subjects/a-study-to-assess-the-bioequivalence-of-trastuzumab-via-92094.html2025-10-16https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-to-evaluate-the-effect-of-injection-site-on-pk--02435.html2025-01-31https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-to-determine-the-effect-of-itraconazole-on-the--12193.html2025-03-27https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-clinical-trial-to-investigate-the-clinical-drug-drug--42815.html2024-11-27https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-investigating--14c--labeled-ro7269162-in-health-13152.html2025-02-27https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-investigating-the-effect-of-different-approved--69906.html2025-03-27https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-to-evaluate-the-effect-of-rifampin-on-the-pharm-89305.html2025-03-27https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-to-assess-the-tolerability-and-safety-of-subcut-84154.html2025-07-01https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-to-evaluate-the-relative-bioavailability-of-two-07512.html2025-07-16https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-to-determine-the-safety--tolerability--pharmaco-89071.html2025-12-10https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-to-evaluate-the-effect-of-food-and-proton-pump--71587.html2026-01-10https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-dose-escalation-study-of-ro7875913-in-healthy-partici-05608.html2026-01-16https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-to-see-how-ro7763505-works-and-how-safe-it-is-w-84422.html2026-03-30https://genentech-clinicaltrials.com/en/trials/healthy-volunteers/a-study-of-multiple-doses-of-orally-administered-ro7795-38973.html2026-03-31https://genentech-clinicaltrials.com/en/trials/kidney-disorder/ckd/a-study-to-evaluate-the-efficacy--safety--and-pharmacok-56434.html2024-08-31https://genentech-clinicaltrials.com/en/trials/kidney-disorder/renal-failure/a-study-of-obinutuzumab-to-evaluate-safety-and-tolerabi-78003.html2024-09-01https://genentech-clinicaltrials.com/en/trials/kidney-disorder/childhood-nephrotic-syndrome/a-study-to-evaluate-the-efficacy-and-safety-of-obinutuz-25529.html2025-03-27https://genentech-clinicaltrials.com/en/trials/kidney-disorder/iga-nephropathy/a-study-to-evaluate-the-efficacy-and-safety-of-ro743465-06097.html2025-03-27https://genentech-clinicaltrials.com/en/trials/kidney-disorder/acute-kidney-injury/a-study-to-evaluate-the-efficacy-and-safety-of-gdc-8264-01033.html2025-03-26https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/t1d/a-study-of-ct-868-in-type-1-diabetes-mellitus-16185.html2025-04-04https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/t2d/a-multiple-ascending-dose-study-to-evaluate-safety-and-tolerabil.html2024-08-31https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/t2d/a-study-to-compare-different-doses-of-ro7795081-with-a--74491.html2025-09-05https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/t2d/a-clinical-study-to-evaluate-the-effects-of-ro7795068-i-18274.html2026-01-21https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/Liver_Failure/a-study-to-evaluate-the-pharmacokinetics-of-divarasib-i-38270.html2025-03-27https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/Liver_Failure/a-study-to-evaluate-the-effect-of-moderate-or-severe-he-53361.html2025-09-10https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/hepatic-insufficiency/a-study-to-investigate-the-effect-of-impaired-hepatic-f-07038.html2024-08-03https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/hepatic-insufficiency/a-study-to-evaluate-the-processing-by-the-body-and-safety-of-pra.html2024-01-29https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/dr/a-study-to-investigate-the-efficacy-and-safety-of-rg777-36226.html2024-09-26https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/dr/a-multicenter--randomized-study-in-participants-with-di-85926.html2025-01-18https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/obesity/a-study-of-ct-388-in-participants-with-obesity-or-overw-25872.html2025-03-27https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/obesity/a-study-of-ct-388-in-participants-who-are-overweight-or-91515.html2025-04-15https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/obesity/a-study-to-assess-efficacy--safety--tolerability--pharm-17109.html2025-05-13https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/obesity/a-study-investigating-the-safety-of-ro7795081-and-the-e-56948.html2025-05-22https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/obesity/a-study-evaluating-the-effect-of-daily-oral-ro7795081-i-63928.html2025-07-29https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/obesity/a-study-to-evaluate-the-effect-of-ro7204239-on-insulin--95286.html2025-09-05https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/obesity/a-clinical-study-to-evaluate-the-effects-of-ro7795068-i-22715.html2026-01-23https://genentech-clinicaltrials.com/en/trials/metabolic-disorder/mash/a-study-to-assess-the-safety--pharmacokinetics--and-act-77734.html2025-04-09https://genentech-clinicaltrials.com/en/trials/cardiovascular-disorder/cardiac-transplant/the-mycophenolate-pregnancy-registry.html2025-12-31https://genentech-clinicaltrials.com/en/trials/cardiovascular-disorder/atherosclerosis/a-study-to-evaluate-the-efficacy--safety--pharmacodynam-38618.html2026-03-05https://genentech-clinicaltrials.com/en/trials/hematologic-diseases/Hemophilia/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-06605.html2024-08-31https://genentech-clinicaltrials.com/en/trials/hematologic-diseases/Hemophilia/a-study-of-emicizumab-administered-subcutaneously--sc---47981.html2024-08-30https://genentech-clinicaltrials.com/en/trials/hematologic-diseases/Hemophilia/a-clinical-trial-to-evaluate-prophylactic-emicizumab-ve-59481.html2024-08-31https://genentech-clinicaltrials.com/en/trials/hematologic-diseases/Hemophilia/a-study-to-evaluate-the-efficacy--safety--and-pharmacok-78611.html2024-08-31https://genentech-clinicaltrials.com/en/trials/hematologic-diseases/Hemophilia/hemophilia-a/a-study-to-evaluate-the-safety-and-tolerability-of-prophylactic-.html2023-03-29https://genentech-clinicaltrials.com/en/trials/blood-disorder/sickle-cell-disease/a-study-evaluating-the-efficacy--safety--pharmacokineti-50959.html2025-03-27https://genentech-clinicaltrials.com/en/trials/blood-disorder/sickle-cell-disease/a-study-evaluating-the-safety--pharmacokinetics--pharma-03990.html2025-03-27https://genentech-clinicaltrials.com/en/trials/blood-disorder/atypical-hemolytic-uremic-syndrome/a-study-evaluating-the-efficacy--safety--pharmacokineti-29406.html2025-07-19https://genentech-clinicaltrials.com/en/trials/blood-disorder/atypical-hemolytic-uremic-syndrome/a-study-evaluating-the-efficacy--safety--pharmacokineti-90194.html2024-11-07https://genentech-clinicaltrials.com/en/trials/blood-disorder/blood-platelet-disorder/a-study-to-assess-the-efficacy-and-safety-of-emicizumab-28219.html2026-02-16https://genentech-clinicaltrials.com/en/trials/immunology/acute-graft-versus-host-disease/a-study-to-assess-the-safety-and-pharmacokinetics-of-gd-54264.html2024-08-31https://genentech-clinicaltrials.com/en/trials/Hemophilia/hemophilia-a/a-study-to-evaluate-the-safety--tolerability--pharmacok-88545.html2025-06-25https://genentech-clinicaltrials.com/en/trials/Hemophilia/hemophilia-a/a-gene-therapy-study-of-spk-8011qq-in-adults-with-sever-87315.html2025-11-11https://genentech-clinicaltrials.com/en/trials/Hemophilia/hemophilia-a/a-study-to-evaluate-the-safety--efficacy--pharmacokinet-22898.html2026-01-24https://genentech-clinicaltrials.com/en/trials/Hemophilia/hemophilia-a/a-study-to-evaluate-overall-health--physical-activity---45581.html2026-01-27https://genentech-clinicaltrials.com/en/trials/Hemophilia/hemophilia-a/a-study-to-evaluate-the-efficacy--safety--pharmacokinet-45752.html2026-01-30https://genentech-clinicaltrials.com/en/trials/Hemophilia/hemophilia-a/a-clinical-study-to-evaluate-the-effects-of-nxt007-comp-53143.html2026-03-24https://genentech-clinicaltrials.com/en/trials/Hemophilia/hemophilia-a/a-clinical-study-to-evaluate-the-effects-of-nxt007-comp-57279.html2026-03-10https://genentech-clinicaltrials.com/en/trials/Hemophilia/hemophilia-a/efficacy--safety--and-pharmacokinetic-study-of-prophylactic-emic.html2026-04-02https://genentech-clinicaltrials.com/en/trials/skin-disease/dermatitis/prurigo/study-to-assess-the-efficacy--safety--and-tolerability--66033.html2025-06-12https://genentech-clinicaltrials.com/en/faq.html2022-03-04https://genentech-clinicaltrials.com/en/faq/what-is-a-clinical-trial.html2023-05-09https://genentech-clinicaltrials.com/en/faq/why-should-i-consider-taking-part-in-a-clinical-trial.html2020-03-05https://genentech-clinicaltrials.com/en/faq/roche-in-clinical-trials.html2023-05-09https://genentech-clinicaltrials.com/en/error/404.html2024-10-29https://genentech-clinicaltrials.com/en/error/403.html2024-10-29https://genentech-clinicaltrials.com/en/privacy-policy.html2020-03-05https://genentech-clinicaltrials.com/en/About.html2022-08-05https://genentech-clinicaltrials.com/en/sitemap.html2023-03-08https://genentech-clinicaltrials.com/en/disease-area-overview.html2022-03-02https://genentech-clinicaltrials.com/en/solr-search.html2024-03-01https://genentech-clinicaltrials.com/en/new-solr-search.html2024-03-04